Gilead Sciences Inc on Tuesday unveiled data from the first human study of its experimental oral COVID-19 antiviral, saying the results in healthy volunteers cleared the way for two large Phase III trials of the drug that have begun enrolling patients.
Researchers chasing long COVID cures are eager to learn whether naltrexone, a generic drug typically used to treat alcohol and opioid addiction, can offer similar benefits to millions suffering from pain, fatigue and brain fog months after a coronavirus infection.
Dec 14 (Reuters) - The Omicron coronavirus variant has been detected in 77 countries since it was first identified three weeks ago, fueling concerns that its large number of mutations will help it spread faster and evade protection provided by COVID-19 vaccines or prior infection. Scientists await answers to these.